iXensor’s Eveline·Care telehealth empowering fertility services to assist patients’ conceptions with at-home test monitoring

Palo Alto, California / Taipei, Taiwan, September 14th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, launches its new Eveline·Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly…

read more

iXensor levels up PixoTest® COVID-19 Ag Test with the launch of PixoHealth data management platform as the security solution for the new normalcy

PixoHealth Pass Admin App and Web Portal empowers safer reopening in the post-pandemic era

The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta Connected point-of-care screening is the critical security mechanism of the post-pandemic normalcy  …

read more

iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies

iXensor launches CE marked PixoTest COVID-19 Antigen Test

iXensor, the pioneer of mobile health, announces today that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. iXensor provides the end-to-end fully digitalized solution to prevent further outbreaks. iXensor’s PixoTest® solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin…

read more

iXensor announces superior clinical accuracy of its fully digitalized PixoTest® POCT COVID-19 Antigen Test and management solution

iXensor, the pioneer of mobile health, is set to launch its end-to-end digital COVID-19 rapid antigen test solution that digitizes the entire user journey from screening, reporting to access control to combat outbreaks. The clinical performance evaluation has demonstrated superior accuracy of the PixoTest® POCT COVID-19 Antigen Test. The test…

read more

iXensor announces its residency at Johnson Innovation’s JLABS @ Shanghai to further develop smartphone-based rapid tests

iXensor joins the Johnson & Johnson Innovation to expand applications of PixoTech technology platform

iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources.   Johnson Innovation…

read more